Lim Seok-a
Seoul National University Hospital|Hematology and Oncology
Seoul Jongno-gu
Last updated
임석아 교수의 유방암 분야 임상경험과 연구가 환자 후기의 신뢰를 뒷받침하는 진료를 함
Medical opinions · Patient reviews0
No reviews yet.
If you've been treated by Lim Seok-a, be the first to leave a review.
Planning to see Lim Seok-a?
Save this doctor and find them again anytime on My page.
Ask other patients
If reviews don't answer your questions, ask patients and caregivers who have been there.
Patient stories: Hematology and Oncology
MoreHospital information
- Hospitals
- Seoul National University Hospital
- Specialties
- More Hematology and Oncology doctors
- Address
- 101 Daehak-ro, Jongno-gu, Seoul
- University
- 서울대학교 의과대학
- Appointments
- 1588-5700Book by phone (1588-5700)
Education and career
Education
- 1999 이화여자대학교 대학원 의학박사
- 1995 이화여자대학교 대학원 의학석사
- 1991 이화여자대학교 의과대학 의학사
Career
- 2024~현재 한국과학기술한림원 의약학부 정회원
- 2021~2023 한국유방암학회 부회장
- 2020~2024 대한암학회 국제위원장
- 2019~현재 서울대학교 암연구소 연구소장
- 2018~2023 대한종양내과학회 학술위원장
- 제목 BRCA genetic testing and counseling in breast cancer: how do we meet our patients' needs?
- 발표지 NPJ breast cancer
- 발표년월 2024-9
- PubmedURL https://www.ncbi.nlm.nih.gov/pubmed/39237557/
- 제목 Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study.
- 발표지 BREAST CANCER
- 발표년월 2024-9
- PubmedURL https://www.ncbi.nlm.nih.gov/pubmed/38884900/
- 제목 Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer.
- 발표지 CANCER SCIENCE
- 발표년월 2024-9
- PubmedURL https://www.ncbi.nlm.nih.gov/pubmed/38979893/
- 제목 Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.
- 발표지 NPJ breast cancer
- 발표년월 2024-9
- PubmedURL https://www.ncbi.nlm.nih.gov/pubmed/39266535/
- 제목 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.
- 발표지 CANCER IMMUNOLOGY IMMUNOTHERAPY
- 발표년월 2024-8
- PubmedURL https://www.ncbi.nlm.nih.gov/pubmed/39105849/
FAQ
- What conditions does Lim Seok-a treat?
- Lim Seok-a (Hematology and Oncology, Seoul National University Hospital) treats conditions such as Gastrointestinal stromal tumor (GIST).
- Where does Lim Seok-a see patients?
- In Hematology and Oncology at Seoul National University Hospital. The hospital address is 101 Daehak-ro, Jongno-gu, Seoul.
- What is Lim Seok-a's specialty?
- Specialty: Hematology and Oncology.
Is any information wrong?
Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.